A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.

about

Agomelatine versus Sertraline: An Observational, Open-labeled and 12 Weeks Follow-up Study on Efficacy and Tolerability.Efficacy and safety of escitalopram in treatment of severe depression in Chinese population.

P2860

Q41602250-84AE6AB2-5CAA-40EC-8749-B69A77B309BF Q47774710-7E379807-0699-4C3A-BB08-404C8998F74C

P2860

A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.

Item

http://www.wikidata.org/entity/Q35918242

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@ast

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@en

type

Item

label

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@ast

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@en

prefLabel

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@ast

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@en

P1476

A Comparative Study of Efficac ...... in Major Depressive Disorder.

@en

P2093

Jayasree Palla

http://www.w3.org/2001/XMLSchema#string

Lakshmana Rao Nambaru

http://www.w3.org/2001/XMLSchema#string

Ravi Babu Komaram

http://www.w3.org/2001/XMLSchema#string

Satyanarayana Murthy Kasturi

http://www.w3.org/2001/XMLSchema#string

Srikrishna Nukala

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation

A rating scale for depression

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline

Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or ag

Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.

Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.

P304

VC05-VC08

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7860/JCDR/2015/12371.6092

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26266196

http://www.w3.org/2001/XMLSchema#string

P932

4525586

http://www.w3.org/2001/XMLSchema#string

A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.

about

P2860

P2860

A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932